Background/Aims: Sepsis is a common disease that continues to increase in prevalence worldwide, and diabetes mellitus may make the situation worse. This study was designed to determine the role of Liver Kinase B1 (LKB1)/adenosine monophosphate-activated protein kinase (AMPK) signaling pathway in diabetic mice complicated with systemic endotoxemia. Methods: The effects of LKB1/AMPK signaling pathway activation on endotoxemia were investigated in streptozotocin induced diabetic mice (STZ-mice) and db/db diabetic mice. Primary peritoneal macrophages and human umbilical vein endothelial cells (HUVECs) monolayers were simultaneously stimulated by both high glucose and LPS and used as a model to investigate the potential molecular mechanisms in vitro. Results: After treatment with LPS, high glucose or both LPS and high glucose, phosphor-AMPK expression was decreased, and moreover, AMPK activation by metformin treatment alleviated the decrease in phosphor-AMPK expression in HUVECs and macrophages as well as in lung tissue. Furthermore, both LPS and high glucose co-treatment decreased LKB1 and phosphor-AMPK expression via enhanced oxidative stress response, and importantly, LKB1 overexpression mediated by adenovirus inhibited the decrease in phosphor-AMPK expression in macrophages and HUVECs. AMPK activation by metformin administration improved the survival of STZ-induced diabetic mice and db/db diabetic mice, which was associated with reduced lung endothelial hyperpermeability and systemic inhigh glucose and LPS stimulation was also alleviated by AMPK activation, which was partly via suppression of VE-cadherin phosphorylation. Conclusion: These data demonstrated that LKB1/AMPK signaling pathway activation improved the survival of diabetic mice complicated
Introduction
Accounting for an estimated 22% of deaths in diabetic patients, infection is a common and serious complication of diabetes, as well as a well-recognized cause of mortality [1, 2] . Previous data indicates that diabetic mice have increased susceptibility to a variety of bacterial infections [3, 4] . Despite the poor prognosis of diabetes complicated with sepsis, very little is known about the mechanisms that confer the increased susceptibility to mortality induced by endotoxemia during diabetes.
response occurs in sepsis, resulting in immunological imbalance [6, 7] . Macrophages and contribute to lung edema and poor compliance. Consequently, septic diabetes patients suffering from shock and acute respiratory distress syndrome experience high mortality. suppression, although the exact mechanisms are not fully elucidated [10, 11] . AMP-activated salvianolic acid A or salvianolic acid B has antidiabetic effect in diabetic animal models the underlying mechanisms were explored. incubated with the indicated concentrations of metformin for 2 h and immunoblotting showed that metphosphorylation pe-P P < 0.05 vs. control. Cells were incubated with normal hours in medium and then treated with or without metformin -toneal macrophages --P ## P < 0.01, # P § § P < 0.01, § P P < 0.05, P P ## P < 0.01, # P < 0.05 vs. Con § § P < 0.01, § P P < 0.05, P most serious histopathological alterations, including cell structure destruction, white blood streptozotocin triggered-diabetic mice.
Materials and Methods

Reagents
protected against sepsis partly via decreased lung permeability in diabetic mice. - permeability basing on the previous studies. However, in this study, metformin did not lower blood glucose levels when administered to diabetic mice in the in vivo serum lipid and glucose metabolism, between diabetic mice treated with and without for part of why metformin did not lower blood glucose levels in endotoxemia mice in this study, but it remained to be further elucidated.
high mortality of sepsis in hosts with diabetes mellitus by demonstrating a dysregulation of cytokine networks and endothelial barrier dysfunction partly due to the suppression of metformin in treating diabetes mellitus complicated with sepsis. 
